Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
NCT06030804

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Led by Peking University First Hospital · Updated on 2025-07-31

4532

Participants Needed

39

Research Sites

263 weeks

Total Duration

On this page

Sponsors

P

Peking University First Hospital

Lead Sponsor

P

Peking University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Along with aging population, cancer incidence and mortality are increasing. However, despite advances in oncology and surgery, long-term survival of cancer patients is far from optimal. Dexmedetomidine is a highly selective alpha 2 adrenergic receptor agonist with sedative, analgesic, and anxiolytic effects. Studies showed that perioperative use of dexmedetomidine reduces delirium and some non-delirium complications after surgery. In long-term follow-up studies of older patients who, for other reasons, were randomized to receive either dexmedetomidine or placebo during intra- or postoperative period, dexmedetomidine use was associated with improved long-term survival. This multicenter randomized trial aims to investigate the effect of perioperative dexmedetomidine on long-term outcomes in older patients undergoing cancer surgery.

CONDITIONS

Official Title

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Who Can Participate

Age: 60Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 60 years or older.
  • Scheduled for radical cancer surgery under general anesthesia with expected duration of 2 hours or longer.
  • Requires patient-controlled intravenous analgesia after surgery.
Not Eligible

You will not qualify if you...

  • Unable to communicate before surgery due to vision, hearing, speech, or other reasons.
  • Undergoing surgery for breast cancer or intracranial tumor.
  • Severe sinus bradycardia (less than 50 beats per minute), sick sinus syndrome, or second-degree or higher atrioventricular block without a pacemaker.
  • Severe liver dysfunction classified as Child-Pugh class C.
  • Severe kidney dysfunction requiring renal replacement therapy before surgery.
  • Currently enrolled in other clinical studies.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 39 locations

1

The First Affiliated Hospital of China University of Science and Technology

Hefei, Anhui, China, 065001

Actively Recruiting

2

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

Hefei, Anhui, China, 230001

Actively Recruiting

3

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

Actively Recruiting

4

Tsinghua University Yuquan Hospital

Beijing, Beijing Municipality, China, 100040

Actively Recruiting

5

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China, 200032

Actively Recruiting

6

The First Affiliated Hospital of Army Medical University (Southwest Hospital)

Chongqing, Chongqing Municipality, China, 400038

Actively Recruiting

7

Fujian Provincial Hospital

Fuzhou, Fujian, China, 350001

Actively Recruiting

8

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China, 350004

Actively Recruiting

9

Fujian Medical University Union Hospital

Fuzhou, Fujian, China, Fujian

Not Yet Recruiting

10

Jinjiang City Hospital (Shanghai Sixth People's Hospital, Fujian Hospital)

Jinjiang, Fujian, China, 362261

Actively Recruiting

11

Guangdong General Hospital

Guangzhou, Guangdong, China, 510080

Actively Recruiting

12

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China, 518034

Actively Recruiting

13

The First Affiliated Hospital of Shenzhen University

Shenzhen, Guangdong, China, 518035

Actively Recruiting

14

The Second Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China, 530005

Actively Recruiting

15

Affiliated Cancer Hospital of Guangxi Medical University

Nanning, Guangxi, China, 530021

Actively Recruiting

16

Zhejiang Cancer Hospital

Zhejiang, Hangzhou, China, 310022

Not Yet Recruiting

17

The Fourth Hospital of Hebei Medical University

Shijiazhuang, Hebei, China, 050011

Actively Recruiting

18

Tangshan Workers' Hospital

Tangshan, Hebei, China, 063000

Not Yet Recruiting

19

The Second Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China, 150001

Actively Recruiting

20

Harbin Medical University Cancer Hospital

Harbin, Heilongjiang, China, 150081

Actively Recruiting

21

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 450052

Actively Recruiting

22

Henan Provincial People's Hospital

Zhengzhou, Henan, China, 463599

Actively Recruiting

23

Xiangya Hospital Central South university

Changsha, Hunan, China, 410119

Actively Recruiting

24

The First Affiliated Hospital of University of South China

Hengyang, Hunan, China, 421005

Not Yet Recruiting

25

Nanjing General Hospital of Nanjing Military Region

Nanjing, Jiangsu, China, 210000

Actively Recruiting

26

Affiliated Drum Tower Hospital, Medical School of Nanjing University

Nanjing, Jiangsu, China, 210008

Actively Recruiting

27

The Second Affiliated Hospital of Suzhou University

Suzhou, Jiangsu, China, 215004

Actively Recruiting

28

Bethune First Hospital Of Jilin University

Changchun, Jilin, China, 130031

Actively Recruiting

29

General hospital of eastern theater command

Nanjing, Nanjing, China, 210002

Not Yet Recruiting

30

General Hospital of Ningxia Medical University

Yinchuan, Ningxia, China, 750003

Not Yet Recruiting

31

People's Hospital of Ningxia Hui Autonomous Region

Yinchuan, Ningxia, China, 750011

Actively Recruiting

32

Xijing Hospital, Fourth Military Medical University

Xi'an, Shaanxi, China, 710032

Actively Recruiting

33

Shandong Provincial Hospital Heze Hospital

Heze, Shandong, China, 274000

Actively Recruiting

34

Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine

Shanghai, Shanghai Municipality, China, 200123

Actively Recruiting

35

Shanxi Cancer Hospital

Taiyuan, Shanxi, China, 030000

Actively Recruiting

36

Shanxi Provincial People's Hospital

Taiyuan, Shanxi, China, 030012

Actively Recruiting

37

Shanxi Bethune Hospital

Taiyuan, Shanxi, China, 030032

Actively Recruiting

38

First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China, 830011

Actively Recruiting

39

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China, 325000

Actively Recruiting

Loading map...

Research Team

D

Dong-Xin Wang, MD,PhD

CONTACT

J

Jia-Hui Ma, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here